Europe:+32-2-535-7543
Asia: +65-6223-2436
Int'l: +1-860-674-8796
US: +1-866-353-3335
  • Chinese
Cover Image

Greece Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2018

Summary

Global Markets Direct's new report, "Greece Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2018" provides key market data on the Greece Cardiovascular Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within ten market categories - Interventional Cardiology, Cardiac Rhythm Management, Peripheral Vascular Devices, Cardiovascular Surgery, Prosthetic Heart Valves, Electrophysiology, Cardiac Assist Devices, Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Prosthetic Devices and External Defibrillators. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct's team of industry experts.

Scope

  • Market size and company share data for Cardiovascular Devices market categories - Interventional Cardiology, Cardiac Rhythm Management, Peripheral Vascular Devices, Cardiovascular Surgery, Prosthetic Heart Valves, Electrophysiology, Cardiac Assist Devices, Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Prosthetic Devices and External Defibrillators.
  • Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within ten market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
  • 2011 company shares and distribution shares data for each of the ten market categories.
  • Global corporate-level profiles of key companies operating within the Greece Cardiovascular Devices market.
  • Key players covered include Medtronic, Inc., Boston Scientific Corporation , Abbott Laboratories , St. Jude Medical, Inc., Biotronik SE & Co. KG , Cordis Corporation and others.

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the Greece Cardiovascular Devices competitive landscape.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What is This Report About?

3. Cardiovascular Devices In Greece

  • 3.1. Cardiovascular Devices, Greece, Overall Revenue ($m), USD Constant, 2004-2018
  • 3.2. Cardiovascular Devices, Greece, Company Share (2010-2011)

4. Cardiac Assist Devices In Greece

  • 4.1. Cardiac Assist Devices Overall Revenue, (2004-2018)
    • 4.1.1. Intra-Aortic Balloon Pumps, Revenue (2004-2018)
    • 4.1.2. Ventricular Assist Devices, Revenue (2004-2018)
  • 4.2. Cardiac Assist Devices Overall Volume (2004-2018)
    • 4.2.1. Intra-Aortic Balloon Pumps, Volume (2004-2018)
    • 4.2.2. Ventricular Assist Devices, Volume (2004-2018)
  • 4.3. Cardiac Assist Devices Average Price (2004-2018)
  • 4.4. Cardiac Assist Devices Distribution Share (2010-2011)
  • 4.5. Cardiac Assist Devices, Greece, Company Share (2010-2011)

5. Cardiac Rhythm Management In Greece

  • 5.1. Cardiac Rhythm Management Overall Revenue, (2004-2018)
    • 5.1.1. Cardiac Resynchronisation Therapy, Revenue (2004-2018)
    • 5.1.2. Implantable Cardioverter Defibrillators, Revenue (2004-2018)
    • 5.1.3. Pacemakers, Revenue (2004-2018)
  • 5.2. Cardiac Rhythm Management Overall Volume (2004-2018)
    • 5.2.1. Cardiac Resynchronisation Therapy, Volume (2004-2018)
    • 5.2.2. Implantable Cardioverter Defibrillators, Volume (2004-2018)
    • 5.2.3. Pacemakers, Volume (2004-2018)
  • 5.3. Cardiac Rhythm Management Average Price (2004-2018)
  • 5.4. Cardiac Rhythm Management Distribution Share (2010-2011)
  • 5.5. Cardiac Rhythm Management, Greece, Company Share (2010-2011)

6. Cardiovascular Monitoring and Diagnostic Devices In Greece

  • 6.1. Cardiovascular Monitoring and Diagnostic Devices Overall Revenue, (2004-2018)
  • 6.2. Cardiovascular Monitoring and Diagnostic Devices Overall Volume (2004-2018)
  • 6.3. Cardiovascular Monitoring and Diagnostic Devices Average Price (2004-2018)
  • 6.4. Cardiovascular Monitoring and Diagnostic Devices Distribution Share (2010-2011)
  • 6.5. Cardiovascular Monitoring and Diagnostic Devices, Greece, Company Share (2010-2011)

7. Cardiovascular Prosthetic Devices In Greece

  • 7.1. Cardiovascular Prosthetic Devices Overall Revenue, (2004-2018)
    • 7.1.1. Septal Occluders, Revenue (2004-2018)
  • 7.2. Cardiovascular Prosthetic Devices Overall Volume (2004-2018)
    • 7.2.1. Septal Occluders, Volume (2004-2018)
  • 7.3. Cardiovascular Prosthetic Devices Average Price (2004-2018)
  • 7.4. Cardiovascular Prosthetic Devices Distribution Share (2010-2011)
  • 7.5. Cardiovascular Prosthetic Devices, Greece, Company Share (2010-2011)

8. Cardiovascular Surgery In Greece

  • 8.1. Cardiovascular Surgery Overall Revenue, (2004-2018)
    • 8.1.1. Beating Heart Surgery Systems, Revenue (2004-2018)
    • 8.1.2. Perfusion Disposables, Revenue (2004-2018)
  • 8.2. Cardiovascular Surgery Overall Volume (2004-2018)
    • 8.2.1. Beating Heart Surgery Systems, Volume (2004-2018)
    • 8.2.2. Perfusion Disposables, Volume (2004-2018)
  • 8.3. Cardiovascular Surgery Average Price (2004-2018)
  • 8.4. Cardiovascular Surgery Distribution Share (2010-2011)
  • 8.5. Cardiovascular Surgery, Greece, Company Share (2010-2011)

9. Electrophysiology In Greece

  • 9.1. Electrophysiology Overall Revenue, (2004-2018)
    • 9.1.1. Electrophysiology Diagnostic Catheters, Revenue (2004-2018)
    • 9.1.2. Electrophysiology Ablation Catheters, Revenue (2004-2018)
  • 9.2. Electrophysiology Overall Volume (2004-2018)
    • 9.2.1. Electrophysiology Diagnostic Catheters, Volume (2004-2018)
    • 9.2.2. Electrophysiology Ablation Catheters, Volume (2004-2018)
  • 9.3. Electrophysiology Average Price (2004-2018)
  • 9.4. Electrophysiology Distribution Share (2010-2011)
  • 9.5. Electrophysiology, Greece, Company Share (2010-2011)

10. External Defibrillators In Greece

  • 10.1. External Defibrillators Overall Revenue, (2004-2018)
  • 10.2. External Defibrillators Overall Volume (2004-2018)
  • 10.3. External Defibrillators Average Price (2004-2018)
  • 10.4. External Defibrillators Distribution Share (2010-2011)
  • 10.5. External Defibrillators, Greece, Company Share (2010-2011)

11. Interventional Cardiology In Greece

  • 11.1. Interventional Cardiology Overall Revenue, (2004-2018)
    • 11.1.1. Cardiac Catheters, Revenue (2004-2018)
    • 11.1.2. Coronary Stents, Revenue (2004-2018)
    • 11.1.3. PTCA Balloons, Revenue (2004-2018)
    • 11.1.4. Arteriotomy Closure Devices, Revenue (2004-2018)
    • 11.1.5. Intravascular Ultrasound Systems (IVUS), Revenue (2004-2018)
  • 11.2. Interventional Cardiology Overall Volume (2004-2018)
    • 11.2.1. Cardiac Catheters, Volume (2004-2018)
    • 11.2.2. Coronary Stents, Volume (2004-2018)
    • 11.2.3. PTCA Balloons, Volume (2004-2018)
    • 11.2.4. Arteriotomy Closure Devices, Volume (2004-2018)
    • 11.2.5. Intravascular Ultrasound Systems (IVUS), Volume (2004-2018)
  • 11.3. Interventional Cardiology Average Price (2004-2018)
  • 11.4. Interventional Cardiology Distribution Share (2010-2011)
  • 11.5. Interventional Cardiology, Greece, Company Share (2010-2011)

12. Peripheral Vascular Devices In Greece

  • 12.1. Peripheral Vascular Devices Overall Revenue, (2004-2018)
    • 12.1.1. Stent Grafts, Revenue (2004-2018)
    • 12.1.2. Inferior Vena Cava Filters (IVCF), Revenue (2004-2018)
    • 12.1.3. Peripheral Guidewires, Revenue (2004-2018)
    • 12.1.4. Peripheral Vascular Stents, Revenue (2004-2018)
    • 12.1.5. Peripheral Embolic Protection Devices, Revenue (2004-2018)
  • 12.2. Peripheral Vascular Devices Overall Volume (2004-2018)
    • 12.2.1. Stent Grafts, Volume (2004-2018)
    • 12.2.2. Inferior Vena Cava Filters (IVCF), Volume (2004-2018)
    • 12.2.3. Peripheral Guidewires, Volume (2004-2018)
    • 12.2.4. Peripheral Guidewires, Volume (2004-2018)
    • 12.2.5. Peripheral Vascular Stents, Volume (2004-2018)
    • 12.2.6. Peripheral Embolic Protection Devices, Volume (2004-2018)
  • 12.3. Peripheral Vascular Devices Average Price (2004-2018)
  • 12.4. Peripheral Vascular Devices Distribution Share (2010-2011)
  • 12.5. Peripheral Vascular Devices, Greece, Company Share (2010-2011)

13. Prosthetic Heart Valves In Greece

  • 13.1. Prosthetic Heart Valves Overall Revenue, (2004-2018)
    • 13.1.1. Mechanical Heart Valves, Revenue (2004-2018)
    • 13.1.2. Tissue Heart Valves, Revenue (2004-2018)
  • 13.2. Prosthetic Heart Valves Overall Volume (2004-2018)
    • 13.2.1. Mechanical Heart Valves, Volume (2004-2018)
    • 13.2.2. Tissue Heart Valves, Volume (2004-2018)
  • 13.3. Prosthetic Heart Valves Average Price (2004-2018)
  • 13.4. Prosthetic Heart Valves Distribution Share (2010-2011)
  • 13.5. Prosthetic Heart Valves, Greece, Company Share (2010-2011)

14. Overview of Key Companies in Greece Cardiovascular Devices Market

  • 14.1. Medtronic, Inc.
    • 14.1.1. Company Overview
  • 14.2. Boston Scientific Corporation
    • 14.2.1. Company Overview
  • 14.3. St. Jude Medical, Inc.
    • 14.3.1. Company Overview
  • 14.4. Abbott Laboratories
    • 14.4.1. Company Overview
  • 14.5. Cordis Corporation
    • 14.5.1. Company Overview
  • 14.6. Biotronik SE & Co. KG
    • 14.6.1. Company Overview
  • 14.7. Sorin S.p.A.
    • 14.7.1. Company Overview
  • 14.8. Edwards Lifesciences Corporation
    • 14.8.1. Company Overview
  • 14.9. Terumo Corporation
    • 14.9.1. Company Overview
  • 14.10. MAQUET GmbH & Co. KG
    • 14.10.1. Company Overview
  • 14.11. C. R. Bard, Inc.
    • 14.11.1. Company Overview
  • 14.12. Biosense Webster, Inc.
    • 14.12.1. Company Overview
  • 14.13. Thoratec Corporation
    • 14.13.1. Company Overview
  • 14.14. AGA Medical Holdings, Inc.
    • 14.14.1. Company Overview
  • 14.15. Volcano Corporation
    • 14.15.1. Company Overview
  • 14.16. Biosensors International Group, Ltd.
    • 14.16.1. Company Overview
  • 14.17. Goodman Co., Ltd.
    • 14.17.1. Company Overview
  • 14.18. Asahi Intecc Co., Ltd.
    • 14.18.1. Company Overview
  • 14.19. Philips Healthcare
    • 14.19.1. Company Overview
  • 14.20. HeartWare International, Inc.
    • 14.20.1. Company Overview
  • 14.21. ev3. Inc.
    • 14.21.1. Company Overview
  • 14.22. GE Healthcare
    • 14.22.1. Company Overview
  • 14.23. Schiller AG
    • 14.23.1. Company Overview
  • 14.24. Teleflex Incorporated
    • 14.24.1. Company Overview
  • 14.25. Berlin Heart GmbH
    • 14.25.1. Company Overview
  • 14.26. W. L. Gore & Associates, Inc.
    • 14.26.1. Company Overview
  • 14.27. Zoll Medical Corporation
    • 14.27.1. Company Overview
  • 14.28. OSI Systems, Inc.
    • 14.28.1. Company Overview
  • 14.29. Welch Allyn Inc.
    • 14.29.1. Company Overview
  • 14.30. Fukuda Denshi Co., Ltd.
    • 14.30.1. Company Overview
  • 14.31. Cardiac Science Corporation
    • 14.31.1. Company Overview
  • 14.32. Covidien plc
    • 14.32.1. Company Overview
  • 14.33. Opto Circuits India Limited
    • 14.33.1. Company Overview
  • 14.34. Nihon Kohden Corporation
    • 14.34.1. Company Overview

15. Appendix

  • 15.1. Global Markets Direct Research Methodology
  • 15.2. Definitions of Markets Covered in the Report
    • 15.2.1. Cardiovascular Devices
  • 15.3. Secondary Research
  • 15.4. Primary Research
  • 15.5. Models
  • 15.6. Forecasts
  • 15.7. Expert Panel Validation
  • 15.8. Currency Conversion
  • 15.9. Contact Us
  • 15.10. Disclaimer

List of Tables

  • Table 1: Cardiovascular Devices, Greece, Overall Revenue ($m), USD Constant, 2004-2018
  • Table 2: Cardiovascular Devices, Greece, Overall Revenue ($m), USD Constant, Historic, 2004-2011
  • Table 3: Cardiovascular Devices, Greece, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
  • Table 4: Cardiovascular Devices, Greece, Company Share by Revenue ($m), USD Constant, 2010-2011
  • Table 5: Cardiac Assist Devices, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Table 6: Cardiac Assist Devices, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Table 7: Intra-Aortic Balloon Pumps, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Table 8: Intra-Aortic Balloon Pumps, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Table 9: Ventricular Assist Devices, Greece, Revenue ($m*) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Table 10: Ventricular Assist Devices, Greece, Revenue ($m*) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Table 11: Cardiac Assist Devices, Greece, Volume (Units) by Segment, Historic, 2004-2011
  • Table 12: Cardiac Assist Devices, Greece, Volume (Units) by Segment, Forecast, 2011-2018
  • Table 13: Intra-Aortic Balloon Pumps, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Table 14: Intra-Aortic Balloon Pumps, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Table 15: Ventricular Assist Devices, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Table 16: Ventricular Assist Devices, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Table 17: Cardiac Assist Devices, Greece, Average Price ($), Historic, 2004-2011
  • Table 18: Cardiac Assist Devices, Greece, Average Price ($), Forecast, 2011-2018
  • Table 19: Cardiac Assist Devices, Greece, Distribution Share by Revenue ($m), USD Constant, 2010-2011
  • Table 20: Cardiac Assist Devices, Greece, Company Share by Revenue ($m), USD Constant, 2010-2011
  • Table 21: Cardiac Rhythm Management, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Table 22: Cardiac Rhythm Management, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Table 23: Cardiac Resynchronisation Therapy, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Table 24: Cardiac Resynchronisation Therapy, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Table 25: Implantable Cardioverter Defibrillators, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Table 26: Implantable Cardioverter Defibrillators, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Table 27: Pacemakers, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Table 28: Pacemakers, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Table 29: Cardiac Rhythm Management, Greece, Volume (Units) by Segment, Historic, 2004-2011
  • Table 30: Cardiac Rhythm Management, Greece, Volume (Units) by Segment, Forecast, 2011-2018
  • Table 31: Cardiac Resynchronisation Therapy, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Table 32: Cardiac Resynchronisation Therapy, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Table 33: Implantable Cardioverter Defibrillators, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Table 34: Implantable Cardioverter Defibrillators, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Table 35: Pacemakers, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Table 36: Pacemakers, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Table 37: Cardiac Rhythm Management, Greece, Average Price ($), Historic, 2004-2011
  • Table 38: Cardiac Rhythm Management, Greece, Average Price ($), Forecast, 2011-2018
  • Table 39: Cardiac Rhythm Management, Greece, Distribution Share by Revenue ($m), USD Constant, 2010-2011
  • Table 40: Cardiac Rhythm Management, Greece, Company Share by Revenue ($m), USD Constant, 2010-2011
  • Table 41: Cardiovascular Monitoring and Diagnostic Devices, Greece, Revenue ($m*) USD Constant, by Segment, Historic, 2004-2011
  • Table 42: Cardiovascular Monitoring and Diagnostic Devices, Greece, Revenue ($m*) USD Constant, by Segment, Forecast, 2011-2018
  • Table 43: Cardiovascular Monitoring and Diagnostic Devices, Greece, Volume (Units) by Segment, Historic, 2004-2011
  • Table 44: Cardiovascular Monitoring and Diagnostic Devices, Greece, Volume (Units) by Segment, Forecast, 2011-2018
  • Table 45: Cardiovascular Monitoring and Diagnostic Devices, Greece, Average Price ($), Historic, 2004-2011
  • Table 46: Cardiovascular Monitoring and Diagnostic Devices, Greece, Average Price ($), Forecast, 2011-2018
  • Table 47: Cardiovascular Monitoring and Diagnostic Devices, Greece, Distribution Share by Revenue ($m), USD Constant, 2010-2011
  • Table 48: Cardiovascular Monitoring and Diagnostic Devices, Greece, Company Share by Revenue ($m), USD Constant, 2010-2011
  • Table 49: Cardiovascular Prosthetic Devices, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Table 50: Cardiovascular Prosthetic Devices, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Table 51: Septal Occluders, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Table 52: Septal Occluders, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Table 53: Cardiovascular Prosthetic Devices, Greece, Volume (Units) by Segment, Historic, 2004-2011
  • Table 54: Cardiovascular Prosthetic Devices, Greece, Volume (Units) by Segment, Forecast, 2011-2018
  • Table 55: Septal Occluders, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Table 56: Septal Occluders, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Table 57: Cardiovascular Prosthetic Devices, Greece, Average Price ($), Historic, 2004-2011
  • Table 58: Cardiovascular Prosthetic Devices, Greece, Average Price ($), Forecast, 2011-2018
  • Table 59: Cardiovascular Prosthetic Devices, Greece, Distribution Share by Revenue ($m), USD Constant, 2010-2011
  • Table 60: Cardiovascular Prosthetic Devices, Greece, Company Share by Revenue ($m), USD Constant, 2010-2011
  • Table 61: Cardiovascular Surgery, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Table 62: Cardiovascular Surgery, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Table 63: Beating Heart Surgery Systems, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Table 64: Beating Heart Surgery Systems, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Table 65: Perfusion Disposables, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Table 66: Perfusion Disposables, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Table 67: Cardiovascular Surgery, Greece, Volume (Units) by Segment, Historic, 2004-2011
  • Table 68: Cardiovascular Surgery, Greece, Volume (Units) by Segment, Forecast, 2011-2018
  • Table 69: Beating Heart Surgery Systems, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Table 70: Beating Heart Surgery Systems, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Table 71: Perfusion Disposables, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Table 72: Perfusion Disposables, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Table 73: Cardiovascular Surgery, Greece, Average Price ($), Historic, 2004-2011
  • Table 74: Cardiovascular Surgery, Greece, Average Price ($), Forecast, 2011-2018
  • Table 75: Cardiovascular Surgery, Greece, Distribution Share by Revenue ($m), USD Constant, 2010-2011
  • Table 76: Cardiovascular Surgery, Greece, Company Share by Revenue ($m), USD Constant, 2010-2011
  • Table 77: Electrophysiology, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Table 78: Electrophysiology, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Table 79: Electrophysiology Diagnostic Catheters, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Table 80: Electrophysiology Diagnostic Catheters, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Table 81: Electrophysiology Ablation Catheters, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Table 82: Electrophysiology Ablation Catheters, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Table 83: Electrophysiology, Greece, Volume (Units) by Segment, Historic, 2004-2011
  • Table 84: Electrophysiology, Greece, Volume (Units) by Segment, Forecast, 2011-2018
  • Table 85: Electrophysiology Diagnostic Catheters, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Table 86: Electrophysiology Diagnostic Catheters, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Table 87: Electrophysiology Ablation Catheters, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Table 88: Electrophysiology Ablation Catheters, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Table 89: Electrophysiology, Greece, Average Price ($), Historic, 2004-2011
  • Table 90: Electrophysiology, Greece, Average Price ($), Forecast, 2011-2018
  • Table 91: Electrophysiology, Greece, Distribution Share by Revenue ($m), USD Constant, 2010-2011
  • Table 92: Electrophysiology, Greece, Company Share by Revenue ($m), USD Constant, 2010-2011
  • Table 93: External Defibrillators, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Table 94: External Defibrillators, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Table 95: External Defibrillators, Greece, Volume (Units) by Segment, Historic, 2004-2011
  • Table 96: External Defibrillators, Greece, Volume (Units) by Segment, Forecast, 2011-2018
  • Table 97: External Defibrillators, Greece, Average Price ($), Historic, 2004-2011
  • Table 98: External Defibrillators, Greece, Average Price ($), Forecast, 2011-2018
  • Table 99: External Defibrillators, Greece, Distribution Share by Revenue ($m), USD Constant, 2010-2011
  • Table 100: External Defibrillators, Greece, Company Share by Revenue ($m), USD Constant, 2010-2011
  • Table 101: Interventional Cardiology, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Table 102: Interventional Cardiology, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Table 103: Cardiac Catheters, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Table 104: Cardiac Catheters, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Table 105: Coronary Stents, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Table 106: Coronary Stents, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Table 107: PTCA Balloons, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Table 108: PTCA Balloons, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Table 109: Arteriotomy Closure Devices, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Table 110: Arteriotomy Closure Devices, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Table 111: Intravascular Ultrasound Systems (IVUS), Greece, Revenue ($m*) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Table 112: Intravascular Ultrasound Systems (IVUS), Greece, Revenue ($m*) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Table 113: Interventional Cardiology, Greece, Volume (Units) by Segment, Historic, 2004-2011
  • Table 114: Interventional Cardiology, Greece, Volume (Units) by Segment, Forecast, 2011-2018
  • Table 115: Cardiac Catheters, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Table 116: Cardiac Catheters, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Table 117: Coronary Stents, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Table 118: Coronary Stents, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Table 119: PTCA Balloons, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Table 120: PTCA Balloons, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Table 121: Arteriotomy Closure Devices, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Table 122: Arteriotomy Closure Devices, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Table 123: Intravascular Ultrasound Systems (IVUS), Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Table 124: Intravascular Ultrasound Systems (IVUS), Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Table 125: Interventional Cardiology, Greece, Average Price ($), Historic, 2004-2011
  • Table 126: Interventional Cardiology, Greece, Average Price ($), Forecast, 2011-2018
  • Table 127: Interventional Cardiology, Greece, Distribution Share by Revenue ($m), USD Constant, 2010-2011
  • Table 128: Interventional Cardiology, Greece, Company Share by Revenue ($m), USD Constant, 2010-2011
  • Table 129: Peripheral Vascular Devices, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Table 130: Peripheral Vascular Devices, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Table 131: Stent Grafts, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Table 132: Stent Grafts, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Table 133: Inferior Vena Cava Filters (IVCF), Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Table 134: Inferior Vena Cava Filters (IVCF), Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Table 135: Peripheral Guidewires, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Table 136: Peripheral Guidewires, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Table 137: Peripheral Vascular Stents, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Table 138: Peripheral Vascular Stents, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Table 139: Peripheral Embolic Protection Devices, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Table 140: Peripheral Embolic Protection Devices, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Table 141: Peripheral Vascular Devices, Greece, Volume (Units) by Segment, Historic, 2004-2011
  • Table 142: Peripheral Vascular Devices, Greece, Volume (Units) by Segment, Forecast, 2011-2018
  • Table 143: Stent Grafts, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Table 144: Stent Grafts, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Table 145: Inferior Vena Cava Filters (IVCF), Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Table 146: Inferior Vena Cava Filters (IVCF), Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Table 147: Peripheral Guidewires, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Table 148: Peripheral Guidewires, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Table 149: Peripheral Vascular Stents, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Table 150: Peripheral Vascular Stents, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Table 151: Peripheral Embolic Protection Devices, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Table 152: Peripheral Embolic Protection Devices, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Table 153: Peripheral Vascular Devices, Greece, Average Price ($), Historic, 2004-2011
  • Table 154: Peripheral Vascular Devices, Greece, Average Price ($), Forecast, 2011-2018
  • Table 155: Peripheral Vascular Devices, Greece, Distribution Share by Revenue ($m), USD Constant, 2010-2011
  • Table 156: Peripheral Vascular Devices, Greece, Company Share by Revenue ($m), USD Constant, 2010-2011
  • Table 157: Prosthetic Heart Valves, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Table 158: Prosthetic Heart Valves, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Table 159: Mechanical Heart Valves, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Table 160: Mechanical Heart Valves, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Table 161: Tissue Heart Valves, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Table 162: Tissue Heart Valves, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Table 163: Prosthetic Heart Valves, Greece, Volume (Units) by Segment, Historic, 2004-2011
  • Table 164: Prosthetic Heart Valves, Greece, Volume (Units) by Segment, Forecast, 2011-2018
  • Table 165: Mechanical Heart Valves, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Table 166: Mechanical Heart Valves, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Table 167: Tissue Heart Valves, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Table 168: Tissue Heart Valves, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Table 169: Prosthetic Heart Valves, Greece, Average Price ($), Historic, 2004-2011
  • Table 170: Prosthetic Heart Valves, Greece, Average Price ($), Forecast, 2011-2018
  • Table 171: Prosthetic Heart Valves, Greece, Distribution Share by Revenue ($m), USD Constant, 2010-2011
  • Table 172: Prosthetic Heart Valves, Greece, Company Share by Revenue ($m), USD Constant, 2010-2011

List of Figures

  • Figure 1: Cardiovascular Devices, Greece, Overall Revenue ($m), USD Constant, 2004-2018
  • Figure 2: Cardiovascular Devices, Greece, Overall Revenue ($m), USD Constant, Historic, 2004-2011
  • Figure 3: Cardiovascular Devices, Greece, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
  • Figure 4: Cardiovascular Devices, Greece, Company Share (%), 2011
  • Figure 5: Cardiac Assist Devices, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Figure 6: Cardiac Assist Devices, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Figure 7: Intra-Aortic Balloon Pumps, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Figure 8: Intra-Aortic Balloon Pumps, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Figure 9: Ventricular Assist Devices, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Figure 10: Ventricular Assist Devices, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Figure 11: Cardiac Assist Devices, Greece, Volume (Units) by Segment, Historic, 2004-2011
  • Figure 12: Cardiac Assist Devices, Greece, Volume (Units) by Segment, Forecast, 2011-2018
  • Figure 13: Intra-Aortic Balloon Pumps, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Figure 14: Intra-Aortic Balloon Pumps, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Figure 15: Ventricular Assist Devices, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Figure 16: Ventricular Assist Devices, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Figure 17: Cardiac Assist Devices, Greece, Company Share (%), 2011
  • Figure 18: Cardiac Rhythm Management, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Figure 19: Cardiac Rhythm Management, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Figure 20: Cardiac Resynchronisation Therapy, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Figure 21: Cardiac Resynchronisation Therapy, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Figure 22: Implantable Cardioverter Defibrillators, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Figure 23: Implantable Cardioverter Defibrillators, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Figure 24: Pacemakers, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Figure 25: Pacemakers, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Figure 26: Cardiac Rhythm Management, Greece, Volume (Units) by Segment, Historic, 2004-2011
  • Figure 27: Cardiac Rhythm Management, Greece, Volume (Units) by Segment, Forecast, 2011-2018
  • Figure 28: Cardiac Resynchronisation Therapy, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Figure 29: Cardiac Resynchronisation Therapy, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Figure 30: Implantable Cardioverter Defibrillators, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Figure 31: Implantable Cardioverter Defibrillators, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Figure 32: Pacemakers, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Figure 33: Pacemakers, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Figure 34: Cardiac Rhythm Management, Greece, Company Share (%), 2011
  • Figure 35: Cardiovascular Monitoring and Diagnostic Devices, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Figure 36: Cardiovascular Monitoring and Diagnostic Devices, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Figure 37: Cardiovascular Monitoring and Diagnostic Devices, Greece, Volume (Units) by Segment, Historic, 2004-2011
  • Figure 38: Cardiovascular Monitoring and Diagnostic Devices, Greece, Volume (Units) by Segment, Forecast, 2011-2018
  • Figure 39: Cardiovascular Monitoring and Diagnostic Devices, Greece, Company Share (%), 2011
  • Figure 40: Cardiovascular Prosthetic Devices, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Figure 41: Cardiovascular Prosthetic Devices, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Figure 42: Septal Occluders, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Figure 43: Septal Occluders, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Figure 44: Cardiovascular Prosthetic Devices, Greece, Volume (Units) by Segment, Historic, 2004-2011
  • Figure 45: Cardiovascular Prosthetic Devices, Greece, Volume (Units) by Segment, Forecast, 2011-2018
  • Figure 46: Septal Occluders, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Figure 47: Septal Occluders, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Figure 48: Cardiovascular Prosthetic Devices, Greece, Company Share (%), 2011
  • Figure 49: Cardiovascular Surgery, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Figure 50: Cardiovascular Surgery, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Figure 51: Beating Heart Surgery Systems, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Figure 52: Beating Heart Surgery Systems, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Figure 53: Perfusion Disposables, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Figure 54: Perfusion Disposables, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Figure 55: Cardiovascular Surgery, Greece, Volume (Units) by Segment, Historic, 2004-2011
  • Figure 56: Cardiovascular Surgery, Greece, Volume (Units) by Segment, Forecast, 2011-2018
  • Figure 57: Beating Heart Surgery Systems, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Figure 58: Beating Heart Surgery Systems, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Figure 59: Perfusion Disposables, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Figure 60: Perfusion Disposables, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Figure 61: Cardiovascular Surgery, Greece, Company Share (%), 2011
  • Figure 62: Electrophysiology, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Figure 63: Electrophysiology, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Figure 64: Electrophysiology Diagnostic Catheters, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Figure 65: Electrophysiology Diagnostic Catheters, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Figure 66: Electrophysiology Ablation Catheters, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Figure 67: Electrophysiology Ablation Catheters, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Figure 68: Electrophysiology, Greece, Volume (Units) by Segment, Historic, 2004-2011
  • Figure 69: Electrophysiology, Greece, Volume (Units) by Segment, Forecast, 2011-2018
  • Figure 70: Electrophysiology Diagnostic Catheters, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Figure 71: Electrophysiology Diagnostic Catheters, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Figure 72: Electrophysiology Ablation Catheters, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Figure 73: Electrophysiology Ablation Catheters, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Figure 74: Electrophysiology, Greece, Company Share (%), 2011
  • Figure 75: External Defibrillators, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Figure 76: External Defibrillators, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Figure 77: External Defibrillators, Greece, Volume (Units) by Segment, Historic, 2004-2011
  • Figure 78: External Defibrillators, Greece, Volume (Units) by Segment, Forecast, 2011-2018
  • Figure 79: External Defibrillators, Greece, Company Share (%), 2011
  • Figure 80: Interventional Cardiology, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Figure 81: Interventional Cardiology, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Figure 82: Cardiac Catheters, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Figure 83: Cardiac Catheters, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Figure 84: Coronary Stents, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Figure 85: Coronary Stents, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Figure 86: PTCA Balloons, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Figure 87: PTCA Balloons, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Figure 88: Arteriotomy Closure Devices, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Figure 89: Arteriotomy Closure Devices, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Figure 90: Intravascular Ultrasound Systems (IVUS), Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Figure 91: Intravascular Ultrasound Systems (IVUS), Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Figure 92: Interventional Cardiology, Greece, Volume (Units) by Segment, Historic, 2004-2011
  • Figure 93: Interventional Cardiology, Greece, Volume (Units) by Segment, Forecast, 2011-2018
  • Figure 94: Cardiac Catheters, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Figure 95: Cardiac Catheters, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Figure 96: Coronary Stents, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Figure 97: Coronary Stents, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Figure 98: PTCA Balloons, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Figure 99: PTCA Balloons, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Figure 100: Arteriotomy Closure Devices, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Figure 101: Arteriotomy Closure Devices, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Figure 102: Intravascular Ultrasound Systems (IVUS), Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Figure 103: Intravascular Ultrasound Systems (IVUS), Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Figure 104: Interventional Cardiology, Greece, Company Share (%), 2011
  • Figure 105: Peripheral Vascular Devices, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Figure 106: Peripheral Vascular Devices, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Figure 107: Stent Grafts, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Figure 108: Stent Grafts, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Figure 109: Inferior Vena Cava Filters (IVCF), Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Figure 110: Inferior Vena Cava Filters (IVCF), Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Figure 111: Peripheral Guidewires, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Figure 112: Peripheral Guidewires, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Figure 113: Peripheral Vascular Stents, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Figure 114: Peripheral Vascular Stents, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Figure 115: Peripheral Embolic Protection Devices, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Figure 116: Peripheral Embolic Protection Devices, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Figure 117: Peripheral Vascular Devices, Greece, Volume (Units) by Segment, Historic, 2004-2011
  • Figure 118: Peripheral Vascular Devices, Greece, Volume (Units) by Segment, Forecast, 2011-2018
  • Figure 119: Stent Grafts, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Figure 120: Stent Grafts, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Figure 121: Inferior Vena Cava Filters (IVCF), Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Figure 122: Inferior Vena Cava Filters (IVCF), Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Figure 123: Peripheral Guidewires, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Figure 124: Peripheral Guidewires, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Figure 125: Peripheral Vascular Stents, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Figure 126: Peripheral Vascular Stents, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Figure 127: Peripheral Embolic Protection Devices, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Figure 128: Peripheral Embolic Protection Devices, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Figure 129: Peripheral Vascular Devices, Greece, Company Share (%), 2011
  • Figure 130: Prosthetic Heart Valves, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Figure 131: Prosthetic Heart Valves, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Figure 132: Mechanical Heart Valves, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Figure 133: Mechanical Heart Valves, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Figure 134: Tissue Heart Valves, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Figure 135: Tissue Heart Valves, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Figure 136: Prosthetic Heart Valves, Greece, Volume (Units) by Segment, Historic, 2004-2011
  • Figure 137: Prosthetic Heart Valves, Greece, Volume (Units) by Segment, Forecast, 2011-2018
  • Figure 138: Mechanical Heart Valves, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Figure 139: Mechanical Heart Valves, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Figure 140: Tissue Heart Valves, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Figure 141: Tissue Heart Valves, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Figure 142: Prosthetic Heart Valves, Greece, Company Share (%), 2011
  • Figure 143: Global Markets Direct Methodology
Show More
Pricing
Back to Top